Dr. Smith's ECG Blog
MARCH 9, 2024
Written by Willy Frick A 67 year old man with a history of hypertension presented with three days of chest pain radiating to his back. He had associated nausea, vomiting, and dyspnea. What do you think? This ECG together with these symptoms is certainly concerning for OMI, but the ECG is not fully diagnostic, and another consideration could be acute pericarditis.
Med Page Today
MARCH 9, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
HCPLive
MARCH 9, 2024
The pioneer in neuroimmune research and itch physiology discusses how treatment innovation has evolved dermatology—and what still needs to be changed in practice.
CTVS
MARCH 9, 2024
At CTVS, our thoracic surgeons treat conditions affecting the esophagus including the most serious issue – esophageal cancer – and benign foregut disease like acid reflux (or GERD) and achalasia. GERD stands for gastroesophageal reflux disease, or more commonly acid reflux, and refers to the occurrence of stomach acid routinely flowing backwards up into the esophagus from the stomach.
HCPLive
MARCH 9, 2024
Data from the phase 2 KNOCKOUT study show risankizumab's sustained benefit in reducing memory cells over 52 weeks in psoriasis patients.
The American Journal of Cardiology
MARCH 9, 2024
Publication date: Available online 9 March 2024 Source: The American Journal of Cardiology Author(s): Stefan Preisendörfer, Virginia Singla, Aditya Bhonsale, Krishna Kancharla, Floyd Thoma, Suresh Mulukutla, Andrew Voigt, Alaa Shalaby, N.A.
HCPLive
MARCH 9, 2024
Hamzavi discusses new late-breaking data from AAD 2024, including major takeaways and safety profile after 52 weeks.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
MARCH 9, 2024
These findings from AAD 2024 did not include statistically significant infliximab response predictors, though it had been the largest reported cohort on the subject to date.
HCPLive
MARCH 9, 2024
Phototherapy is consistently beneficial for patient-reported and clinical outcomes regardless of the location, according to late-breaking data at AAD 2024.
Expert insights. Personalized for you.
116 
Let's personalize your content